WO2009053628A3 - Nouveaux composes, préparation et utilisations - Google Patents
Nouveaux composes, préparation et utilisations Download PDFInfo
- Publication number
- WO2009053628A3 WO2009053628A3 PCT/FR2008/051838 FR2008051838W WO2009053628A3 WO 2009053628 A3 WO2009053628 A3 WO 2009053628A3 FR 2008051838 W FR2008051838 W FR 2008051838W WO 2009053628 A3 WO2009053628 A3 WO 2009053628A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel compounds
- preparation
- relates
- present
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne de nouveaux composés, les compositions pharmaceutiques les comprenant ainsi que leurs applications thérapeutiques dans les domaines de la santé humaine et animale. La présente invention a également trait à un procédé de préparation de ces composés.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0758229 | 2007-10-11 | ||
FR0758229A FR2922210A1 (fr) | 2007-10-11 | 2007-10-11 | Nouveaux composes, preparation et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009053628A2 WO2009053628A2 (fr) | 2009-04-30 |
WO2009053628A3 true WO2009053628A3 (fr) | 2009-06-18 |
Family
ID=39281755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2008/051838 WO2009053628A2 (fr) | 2007-10-11 | 2008-10-10 | Nouveaux composes, préparation et utilisations |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2922210A1 (fr) |
WO (1) | WO2009053628A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0610644B8 (pt) | 2005-04-04 | 2021-05-25 | Univ Florida | composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável. |
CN104003955A (zh) | 2007-03-15 | 2014-08-27 | 佛罗里达大学研究基金公司 | 去铁硫辛聚醚类似物 |
GB0918722D0 (en) * | 2009-10-26 | 2009-12-09 | Univ Birmingham | Anti cancer agent |
CA2859406C (fr) | 2011-12-16 | 2020-08-25 | University Of Florida Research Foundation, Inc. | Utilisation d'analogues de 4'-desferrithiocine |
JP6838966B2 (ja) | 2013-11-22 | 2021-03-03 | ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. | デスフェリチオシン類似体およびその使用 |
WO2015077652A1 (fr) * | 2013-11-22 | 2015-05-28 | University Of Florida Research Foundation, Inc. | Analogues de la désazadesferrithiocine et leurs utilisations |
CN107708693A (zh) | 2015-04-27 | 2018-02-16 | 佛罗里达大学研究基金会 | 代谢程序化的金属螯合剂及其用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034949A1 (fr) * | 2003-09-09 | 2005-04-21 | University Of Florida | Derives de desferrithiocine et leur utilisation en tant que chelateurs du fer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1585639A (zh) * | 1998-09-21 | 2005-02-23 | 佛罗里达大学研究基金会 | 抗疟疾制剂 |
-
2007
- 2007-10-11 FR FR0758229A patent/FR2922210A1/fr active Pending
-
2008
- 2008-10-10 WO PCT/FR2008/051838 patent/WO2009053628A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034949A1 (fr) * | 2003-09-09 | 2005-04-21 | University Of Florida | Derives de desferrithiocine et leur utilisation en tant que chelateurs du fer |
Non-Patent Citations (1)
Title |
---|
HOVEYDA H R ET AL: "DESIGN AND SYNTHESIS OF MULTIDENTATE 2-(2'-HYDROXYPHENYL)-2-THIAZOLI NES FOR BIOMEDICAL APPLICATION", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 48, no. 25, 1992, pages 5219 - 5226, XP001160881, ISSN: 0040-4020 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009053628A2 (fr) | 2009-04-30 |
FR2922210A1 (fr) | 2009-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010069532A8 (fr) | Anticorps dirigés contre l'angiopoïétine 2 humaine | |
WO2008012470A3 (fr) | Derives d'imidazolones substitues, preparation et utilisations | |
WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
IL234166B (en) | Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine | |
WO2007118963A3 (fr) | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations | |
IL193340A0 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
IL189008A (en) | History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane | |
IL208203A (en) | Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations | |
WO2009129246A3 (fr) | Compositions et leurs procédés de préparation et d'utilisation | |
TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
IL193339A0 (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
SI2036892T1 (sl) | Derivati tetrahidro h benzazepinov postopek za njihovo pripravo in farmacevtski sestavkiki jih vsebujejo | |
TW200738699A (en) | 4-Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2009053628A3 (fr) | Nouveaux composes, préparation et utilisations | |
WO2010021607A3 (fr) | Préparation pharmaceutique | |
WO2008087366A3 (fr) | Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation | |
EP2042494A4 (fr) | Composés de thiazole 2,4,5-trisubstitués, méthodes de préparation, compositions pharmaceutiques et leurs utilisations à des fins médicales | |
EP2241569A4 (fr) | Composés de thiénopyridazine, leurs préparations, compositions pharmaceutiques et utilisations | |
IL213452A0 (en) | Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof | |
EP2167083A4 (fr) | Nouveaux 1- hétéroaryl-3-azabicycloý3.1.0¨hexanes, leurs méthodes de préparation et leur utilisation comme médicaments | |
WO2006134021A3 (fr) | Procede de preparation de nouveaux sels de tiotropium, nouveaux sels de tiotropium en tant que tels et compositions pharmaceutiques associees | |
PT1742927E (pt) | Derivados do ácido butanóico, processos para a sua preparação, composições farmacêuticas que os contêm, e suas aplicações terapêuticas | |
PT2231598E (pt) | Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham | |
WO2007009686A3 (fr) | Composes de pyrazoline substituee, preparation et utilisation de ceux-ci comme medicaments | |
EP2196463A4 (fr) | Procédé de préparation d'acide 5,6-diméthylxanthone-acétique, dérivés ainsi obtenus et formulations pharmaceutiques de ceux-ci |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08841252 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08841252 Country of ref document: EP Kind code of ref document: A2 |